Biotechnology Pharmaceutical Market in US 2009 2013

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Cancer Drug News 24 NOVEMBER 2014

Cancer Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 12 pages

Industry Trend Analysis - BMS/Merck Battle For Melanoma Market Share Industry Brief - Revlimid Gains Swissmedic Approval For r/r MCL Industry Brief - Teva Launches Liquid Formulation Of Treanda Injection In US Industry Brief - BerGenBio's BGB324 Gains FDA ODD For AML Industry Trend Analysis - GSK Collaboration ...

Industries: Drug and Medication | Countries: United States

Anti-Infective Drug News 24 NOVEMBER 2014

Anti-Infective Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 16 pages

Industry Trend Analysis - AbbVie To Put Pressure On Gilead With Prospective HCV Approval Industry Brief - Pfizer's Trumenba Available In US Industry Brief - RedHill's RHB-105 Gains FDA QIDP Designation For H. Pylori Treatment Industry Brief - Cempra Granted BARDA Funding For Solithromycin Paediatric ...

Industries: Drug and Medication | Countries: United States, Canada, Switzerland

Hayat Pharmaceutical Industries Co PSC

Hayat Pharmaceutical Industries Co PSC

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Hayat Pharmaceutical Industries Co PSC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Agennix AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Germany, United States

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

ALIGN Pharmaceuticals, LLC. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: United States

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

AVAX Technologies, Inc. (AVXT) - Strategic SWOT Analysis Review

AVAX Technologies, Inc. (AVXT) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary AVAX Technologies, Inc. (AVAX) is a biotechnology company. The company develops and commercializes individualized vaccine therapies and technologies used in the treatment of oncology-related diseases. Its AC vaccine technology is an immunotherapeutic treatment that educates the patient's immune ...

Industries: Drug and Medication | Countries: United States

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Avastra Sleep Centres Limited (Avastra) is a publicly held Australia based company that operates diagnostic sleep centers. It is one of the largest networks of sleep specialists in the US. The company operates under three business segments namely Comprehensive Care, Sleep Diagnostics, and Clinical ...

Industries: Drug Discovery and Development | Countries: Australia, United States

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Herborium Group, Inc. (Herborium) is a botanical therapeutics company. The company develops, licenses, and markets botanical based medicinal products used for the treatment of unmet medical needs. Its products include acnease, lasting energy, for him and her, liver activator series, all botanical ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.